Last Updated on July 21, 2024 by The Health Master
Barcodes
In a significant move to safeguard public health, India’s drug regulatory authority is gearing up for stricter enforcement of product identification with respect to barcodes.
The focus? Implementing mandatory barcodes or QR codes on the top 300 pharmaceutical brands across the country.
This initiative, spearheaded by the National Pharmaceutical Pricing Authority (NPPA), aims to combat the circulation of counterfeit drugs and ensure the safety of millions of patients.
Why Barcodes?
The rampant issue of counterfeit drugs poses a serious threat to patient well-being.
These fake medications often lack the necessary active ingredients or contain harmful substances, potentially leading to adverse reactions or treatment failure.
Barcodes, however, act as a powerful weapon in this fight.
Enhanced Traceability:
By scanning the barcode on a medicine package, pharmacists and healthcare providers can gain instant access to crucial information, including the product’s manufacturing license and batch number.
This transparency allows for efficient tracking of the drug’s journey from source to shelf, facilitating the identification and removal of counterfeit products from the supply chain.
Empowering Patients:
The widespread adoption of barcodes empowers patients to take an active role in ensuring the authenticity of their medications.
With the help of readily available scanning apps, patients can verify the legitimacy of their drugs at the point of purchase, fostering greater peace of mind.
Targeted Action
The focus on the top 300 brands strategically targets a broad spectrum of medications commonly used by Indian citizens.
This list reportedly encompasses essential drugs across various therapeutic categories, including:
- Analgesics and Pain Relievers: Medications used to manage pain, such as Ibuprofen and Paracetamol.
- Anti-Platelet Medications: Drugs that prevent blood clots, like Aspirin and Clopidogrel.
- Vitamins and Nutritional Supplements: Essential dietary components for overall health.
- Blood-Sugar-Lowering Drugs: Medications used to treat diabetes, such as Metformin and Glimepiride.
- Contraceptives: Birth control medications.
This comprehensive approach ensures that some of the most in-demand drugs receive heightened protection against counterfeiting, safeguarding the health of a vast population segment.
Joint Task Force
To ensure the successful execution of this crucial initiative, sources indicate the establishment of a joint task force.
This collaborative effort will likely involve stakeholders from various sectors, including:
- Drug regulatory authorities
- Pharmaceutical manufacturers
- Healthcare providers
- Law enforcement agencies
By working in unison, these entities can streamline the implementation of barcoding systems, strengthen enforcement measures against counterfeiters, and foster a robust ecosystem for safe and genuine medications in India.
The mandatory implementation of barcodes on top pharmaceutical brands marks a significant step forward in India’s fight against counterfeit drugs.
This initiative, driven by the NPPA, empowers both patients and healthcare professionals, ultimately safeguarding public health and promoting trust in the nation’s pharmaceutical sector.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
DTAB advocates Bar Codes and QR Codes on Vaccine Products
Bar Code or QR Code: Implementation mandated for Top 300 Brand Drugs from August 1, 2023
QR Codes in Pharma: From Advisory to Action
Barcodes: Extension of Barcode Rules to Safeguard 11 APIs
Bar code or QR code for 300 brands: Govt notifies these drugs under Schedule H2
USFDA approval granted for generic Bromfenac Ophthalmic Solution
NPPA Seeks Clarity on Regulatory Requirements for this Inhaler Device
Inspections to be started for compliance of Revised Schedule M: Tamil Nadu
Govt issues Zika virus advisory: Urgent Action Needed
Budget 2024: Indian Pharma Sector seek incentives for innovation
CDSCO Panel approval granted for Clinical Trial of this Anti Cancer Drug
USFDA approval granted for this BP lowering drug
IPC flags side effects of heart, Glaucoma medicines
High Court: Expedite framing policy for online sale of drugs
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
